Rigel Pharmaceuticals (RIGL) Receivables - Net (2013 - 2026)
Rigel Pharmaceuticals (RIGL) posted quarterly Receivables - Net of $49.9 million for Q1 2026, up 1564.83% year-over-year from $3.0 million in Q1 2025, and down 3.51% quarter-over-quarter from $51.8 million in Q4 2025.
Rigel Pharmaceuticals (RIGL) Receivables - Net (2013 - 2026) Analysis & Trends
Rigel Pharmaceuticals' Receivables - Net history runs 13 years deep, the most recent figure standing at $49.9 million for Q1 2026.
- In Q1 2026, Receivables - Net rose 1564.83% year-over-year to $49.9 million; the TTM figure through Mar 2026 stood at $49.9 million (up 1564.83% YoY), while the FY2025 annual figure was $51.8 million, up 24.39% from the prior year.
- Receivables - Net for Q1 2026 stood at $49.9 million, down from $51.8 million in the prior quarter.
- The five-year high for Receivables - Net was $51.8 million in Q4 2025, with the low at $3.0 million in Q1 2025.
- The 5-year median for Receivables - Net is $28.9 million (2024), against an average of $28.9 million.
- The sharpest annual moves came in 2022 and 2026: Receivables - Net sank 89.28% in 2022, then jumped 1564.83% in 2026.
- Rigel Pharmaceuticals' Receivables - Net stood at $20.0 million in 2022, then soared by 52.75% to $30.6 million in 2023, then surged by 36.22% to $41.6 million in 2024, then climbed by 24.39% to $51.8 million in 2025, then slipped by 3.51% to $49.9 million in 2026.
- Business Quant data shows RIGL's Receivables - Net at $49.9 million in Q1 2026, $51.8 million in Q4 2025, and $45.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Rigel Pharmaceuticals | 795.39 Mn | 700.06 Mn | 70.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 56.04 Mn |
| Jun 30, 2026 | 56.04 Mn |
| Mar 31, 2026 | 49.95 Mn |
| Mar 31, 2026 | 49.95 Mn |
| Dec 31, 2025 | 51.76 Mn |
| Dec 31, 2025 | 51.76 Mn |
| Sep 30, 2025 | 45.93 Mn |
| Sep 30, 2025 | 45.93 Mn |
| Jun 30, 2025 | 39.91 Mn |
| Jun 30, 2025 | 39.91 Mn |
| Mar 31, 2025 | 3.00 Mn |
| Mar 31, 2025 | 3.00 Mn |
| Dec 31, 2024 | 41.62 Mn |
| Dec 31, 2024 | 41.62 Mn |
| Sep 30, 2024 | 30.58 Mn |
| Sep 30, 2024 | 30.58 Mn |
| Jun 30, 2024 | 28.90 Mn |
| Jun 30, 2024 | 28.90 Mn |
| Mar 31, 2024 | 27.51 Mn |
| Mar 31, 2024 | 27.51 Mn |